| histone modification | GO:0016570 | 159 | 0.997 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.994 | |
| histone methylation | GO:0016571 | 71 | 0.993 | |
| chromatin modification | GO:0016568 | 187 | 0.990 | |
| chromatin organization | GO:0006325 | 206 | 0.980 | |
| regionalization | GO:0003002 | 337 | 0.973 | Mouse |
| regulation of histone methylation | GO:0031060 | 30 | 0.967 | |
| dna metabolic process | GO:0006259 | 303 | 0.958 | |
| histone lysine methylation | GO:0034968 | 50 | 0.957 | |
| stem cell fate specification | GO:0048866 | 3 | 0.950 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.901 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.898 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.890 | |
| blastocyst development | GO:0001824 | 80 | 0.848 | |
| methylation | GO:0032259 | 134 | 0.843 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.839 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.826 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.821 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.814 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.811 | |
| protein methylation | GO:0006479 | 81 | 0.779 | |
| macromolecule methylation | GO:0043414 | 120 | 0.778 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.770 | |
| dna methylation | GO:0006306 | 43 | 0.762 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.761 | |
| spermatogenesis | GO:0007283 | 284 | 0.751 | Worm |
| regulation of histone modification | GO:0031056 | 56 | 0.740 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.737 | |
| histone acetylation | GO:0016573 | 41 | 0.723 | |
| embryonic placenta development | GO:0001892 | 98 | 0.698 | |
| skeletal system development | GO:0001501 | 356 | 0.679 | |
| protein alkylation | GO:0008213 | 81 | 0.678 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.646 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.639 | |
| hypermethylation of cpg island | GO:0044027 | 3 | 0.632 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.605 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.582 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.580 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.563 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.515 | |
| forebrain development | GO:0030900 | 302 | 0.510 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.498 | |
| rhythmic process | GO:0048511 | 174 | 0.494 | Mouse |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.485 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.469 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.461 | |
| respiratory tube development | GO:0030323 | 167 | 0.457 | Mouse |
| regulation of chromatin modification | GO:1903308 | 57 | 0.435 | |
| male gamete generation | GO:0048232 | 285 | 0.418 | Worm |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.414 | |
| protein acylation | GO:0043543 | 64 | 0.402 | |
| t cell differentiation | GO:0030217 | 174 | 0.395 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.394 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.392 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.389 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.386 | |
| olfactory learning | GO:0008355 | 2 | 0.383 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.382 | |
| gene silencing | GO:0016458 | 38 | 0.358 | |
| dna alkylation | GO:0006305 | 43 | 0.357 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.351 | |
| digestive system development | GO:0055123 | 200 | 0.338 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.329 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.319 | |
| muscle tissue development | GO:0060537 | 308 | 0.318 | Mouse |
| gland development | GO:0048732 | 330 | 0.314 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.310 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.308 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.293 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.289 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.288 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.288 | |
| mesoderm development | GO:0007498 | 100 | 0.282 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.280 | |
| chromatin silencing | GO:0006342 | 15 | 0.266 | |
| circadian rhythm | GO:0007623 | 114 | 0.262 | Mouse |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.253 | |
| response to peptide hormone | GO:0043434 | 127 | 0.249 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.246 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.242 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.240 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.237 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.236 | |
| cytokine production | GO:0001816 | 319 | 0.236 | |
| endomembrane system organization | GO:0010256 | 147 | 0.235 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.233 | |
| male meiosis | GO:0007140 | 37 | 0.233 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.229 | |
| multicellular organism growth | GO:0035264 | 161 | 0.226 | |
| histone h4 k12 acetylation | GO:0043983 | 2 | 0.224 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.224 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.222 | |
| learning or memory | GO:0007611 | 148 | 0.222 | |
| cognition | GO:0050890 | 149 | 0.220 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.220 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.215 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.215 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.214 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.210 | |
| dna modification | GO:0006304 | 50 | 0.207 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.206 | |
| camera type eye development | GO:0043010 | 266 | 0.204 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.199 | |
| stem cell maintenance | GO:0019827 | 130 | 0.193 | |
| respiratory system development | GO:0060541 | 190 | 0.188 | Mouse |
| axonogenesis | GO:0007409 | 274 | 0.184 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.183 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.180 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.171 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.171 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.168 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.167 | |
| neural tube formation | GO:0001841 | 108 | 0.167 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.156 | |
| stem cell differentiation | GO:0048863 | 268 | 0.154 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.153 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.153 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.153 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.152 | |
| neural tube development | GO:0021915 | 160 | 0.151 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.150 | |
| germ cell development | GO:0007281 | 185 | 0.149 | Worm |
| placenta development | GO:0001890 | 140 | 0.147 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.147 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.146 | |
| cell fate specification | GO:0001708 | 72 | 0.146 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.146 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.146 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.144 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.144 | |
| blastocyst formation | GO:0001825 | 33 | 0.142 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.142 | |
| chemotaxis | GO:0006935 | 247 | 0.142 | |
| digestive tract development | GO:0048565 | 190 | 0.140 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.140 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.138 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.137 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.135 | |
| segmentation | GO:0035282 | 93 | 0.133 | Mouse |
| formation of primary germ layer | GO:0001704 | 77 | 0.130 | |
| locomotor rhythm | GO:0045475 | 8 | 0.128 | |
| epithelial tube formation | GO:0072175 | 130 | 0.128 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.126 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.126 | |
| dendrite development | GO:0016358 | 115 | 0.123 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.123 | |
| external genitalia morphogenesis | GO:0035261 | 1 | 0.121 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.120 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.119 | |
| primary neural tube formation | GO:0014020 | 95 | 0.118 | |
| regulation of cell size | GO:0008361 | 72 | 0.118 | |
| regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry | GO:1900094 | 2 | 0.118 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.118 | |
| regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter | GO:0035947 | 7 | 0.116 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.115 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.115 | |
| amine metabolic process | GO:0009308 | 45 | 0.114 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.114 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.113 | |
| gastrulation | GO:0007369 | 116 | 0.113 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.112 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.112 | |
| artery development | GO:0060840 | 53 | 0.112 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.111 | |
| oocyte differentiation | GO:0009994 | 35 | 0.110 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.110 | |
| gonad development | GO:0008406 | 141 | 0.110 | |
| phagocytosis | GO:0006909 | 66 | 0.109 | |
| regulation of response to drug | GO:2001023 | 2 | 0.109 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.109 | |
| stem cell fate commitment | GO:0048865 | 5 | 0.109 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.108 | |
| nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry | GO:1900164 | 2 | 0.107 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.107 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.106 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.105 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.105 | |
| neural tube closure | GO:0001843 | 90 | 0.104 | |
| limb development | GO:0060173 | 166 | 0.102 | |
| innate immune response | GO:0045087 | 157 | 0.102 | |
| jak stat cascade | GO:0007259 | 42 | 0.100 | |
| serine phosphorylation of stat protein | GO:0042501 | 3 | 0.098 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.097 | |
| male meiosis i | GO:0007141 | 16 | 0.096 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.095 | |
| appendage development | GO:0048736 | 166 | 0.094 | |
| t cell activation | GO:0042110 | 289 | 0.093 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.093 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.093 | |
| germ line stem cell division | GO:0042078 | 2 | 0.092 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.092 | |
| somite development | GO:0061053 | 81 | 0.092 | Mouse |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.092 | |
| hair cycle | GO:0042633 | 90 | 0.092 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.091 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.091 | |
| somatic diversification of t cell receptor genes | GO:0002568 | 5 | 0.091 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.090 | |
| granulocyte differentiation | GO:0030851 | 17 | 0.090 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.089 | |
| oogenesis | GO:0048477 | 56 | 0.088 | Worm |
| ovarian follicle development | GO:0001541 | 40 | 0.086 | |
| response to inorganic substance | GO:0010035 | 96 | 0.086 | |
| face development | GO:0060324 | 38 | 0.086 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.085 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.085 | |
| response to peptide | GO:1901652 | 136 | 0.085 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.084 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.084 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.083 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.083 | |
| limb morphogenesis | GO:0035108 | 149 | 0.083 | |
| regulation of dna templated transcription elongation | GO:0032784 | 10 | 0.082 | |
| defense response to bacterium | GO:0042742 | 119 | 0.082 | |
| gene silencing by rna | GO:0031047 | 19 | 0.082 | |
| cartilage development | GO:0051216 | 140 | 0.080 | |
| n terminal protein amino acid modification | GO:0031365 | 6 | 0.079 | Human |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.079 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.079 | |
| response to estrogen | GO:0043627 | 24 | 0.079 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.078 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.078 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.077 | |
| synaptic transmission | GO:0007268 | 329 | 0.077 | |
| lipid localization | GO:0010876 | 126 | 0.076 | Worm |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.076 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.075 | |
| response to nitric oxide | GO:0071731 | 4 | 0.074 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.074 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.074 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.073 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.073 | |
| compound eye development | GO:0048749 | 1 | 0.073 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.073 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.073 | |
| glucose homeostasis | GO:0042593 | 128 | 0.072 | |
| positive regulation of antimicrobial peptide biosynthetic process | GO:0002807 | 1 | 0.072 | |
| liver development | GO:0001889 | 66 | 0.072 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.071 | |
| protein deacetylation | GO:0006476 | 32 | 0.070 | |
| negative regulation of growth | GO:0045926 | 99 | 0.069 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.069 | |
| protein ubiquitination | GO:0016567 | 171 | 0.068 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.068 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.068 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.068 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.068 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.068 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.068 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.067 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.067 | |
| stem cell development | GO:0048864 | 219 | 0.067 | |
| regulation of cell cycle checkpoint | GO:1901976 | 9 | 0.066 | |
| epithalamus development | GO:0021538 | 2 | 0.065 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.065 | |
| spermatid differentiation | GO:0048515 | 115 | 0.065 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.065 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.064 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.064 | |
| gall bladder development | GO:0061010 | 2 | 0.063 | |
| lung development | GO:0030324 | 164 | 0.063 | Mouse |
| microtubule based process | GO:0007017 | 236 | 0.063 | |
| ossification | GO:0001503 | 216 | 0.063 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.063 | |
| response to hyperoxia | GO:0055093 | 2 | 0.062 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.062 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.062 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.062 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.060 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.060 | |
| positive regulation of binding | GO:0051099 | 49 | 0.059 | Mouse |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.059 | |
| erbb signaling pathway | GO:0038127 | 32 | 0.059 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.059 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.059 | |
| hexose metabolic process | GO:0019318 | 98 | 0.059 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.058 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.058 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.058 | |
| regulation of transcription involved in primary germ layer cell fate commitment | GO:0060796 | 2 | 0.057 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.057 | |
| positive regulation of mesoderm development | GO:2000382 | 2 | 0.057 | |
| endocytosis | GO:0006897 | 168 | 0.057 | |
| synapse organization | GO:0050808 | 125 | 0.057 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.057 | |
| mrna metabolic process | GO:0016071 | 84 | 0.057 | |
| nucleosome positioning | GO:0016584 | 4 | 0.057 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.056 | |
| regulation of transcription involved in cell fate commitment | GO:0060850 | 15 | 0.056 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.055 | |
| memory | GO:0007613 | 58 | 0.055 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.055 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.054 | |
| female gamete generation | GO:0007292 | 74 | 0.054 | Worm |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.054 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.054 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.054 | |
| type i pneumocyte differentiation | GO:0060509 | 7 | 0.052 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.052 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.052 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.052 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.052 | |
| negative regulation of nfat protein import into nucleus | GO:0051534 | 3 | 0.052 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.052 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.051 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.051 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.051 | |
| bmp signaling pathway involved in mesodermal cell fate specification | GO:0060803 | 1 | 0.051 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.051 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.050 | |
| mammary gland epithelial cell proliferation | GO:0033598 | 24 | 0.050 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.050 | |
| lipid storage | GO:0019915 | 36 | 0.050 | Worm |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.050 | |
| tube formation | GO:0035148 | 140 | 0.050 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.049 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.049 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.049 | |
| dna hypermethylation | GO:0044026 | 3 | 0.049 | |
| regulation of protein stability | GO:0031647 | 52 | 0.049 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.049 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.048 | |
| lung epithelium development | GO:0060428 | 37 | 0.048 | |
| regulation of binding | GO:0051098 | 111 | 0.048 | Mouse |
| regulation of innate immune response | GO:0045088 | 91 | 0.048 | |
| body fluid secretion | GO:0007589 | 53 | 0.047 | |
| genitalia development | GO:0048806 | 37 | 0.047 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.047 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.047 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.046 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.046 | |
| regulation of autophagy | GO:0010506 | 30 | 0.046 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.046 | |
| biomineral tissue development | GO:0031214 | 64 | 0.045 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.045 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.045 | |
| neuron maturation | GO:0042551 | 29 | 0.045 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.044 | |
| dna repair | GO:0006281 | 107 | 0.044 | |
| histone deacetylation | GO:0016575 | 26 | 0.044 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.044 | |
| response to nutrient levels | GO:0031667 | 109 | 0.044 | |
| glucose metabolic process | GO:0006006 | 92 | 0.044 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.044 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.044 | |
| regulation of gene expression by genetic imprinting | GO:0006349 | 15 | 0.044 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.044 | |
| negative regulation of histone methylation | GO:0031061 | 10 | 0.044 | |
| protein catabolic process | GO:0030163 | 221 | 0.043 | |
| rna processing | GO:0006396 | 105 | 0.042 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.042 | |
| nuclear transport | GO:0051169 | 139 | 0.042 | |
| cellularization | GO:0007349 | 1 | 0.042 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.042 | |
| nephron development | GO:0072006 | 109 | 0.042 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.042 | |
| pole plasm assembly | GO:0007315 | 2 | 0.042 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.042 | |
| regulation of dna binding | GO:0051101 | 39 | 0.041 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.041 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.041 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.041 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.041 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.041 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.041 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.041 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.040 | |
| endoderm formation | GO:0001706 | 20 | 0.040 | |
| chromatin remodeling | GO:0006338 | 32 | 0.040 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.040 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.040 | Mouse |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.040 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.040 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.040 | |
| regulation of ossification | GO:0030278 | 112 | 0.040 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.040 | |
| positive regulation of antibacterial peptide biosynthetic process | GO:0006963 | 1 | 0.040 | |
| cellular response to starvation | GO:0009267 | 57 | 0.040 | |
| regulation of stem cell maintenance | GO:2000036 | 17 | 0.040 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.039 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.039 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.039 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.039 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.039 | |
| circadian behavior | GO:0048512 | 13 | 0.039 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.038 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.038 | Mouse |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.038 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.038 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.038 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.038 | |
| response to alcohol | GO:0097305 | 48 | 0.037 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.037 | |
| body morphogenesis | GO:0010171 | 45 | 0.037 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.037 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.037 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.037 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.037 | |
| chromatin assembly | GO:0031497 | 13 | 0.037 | |
| face morphogenesis | GO:0060325 | 29 | 0.037 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.036 | |
| negative regulation of cell growth involved in cardiac muscle cell development | GO:0061052 | 2 | 0.036 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.036 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.036 | |
| spleen development | GO:0048536 | 39 | 0.036 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.036 | |
| bone development | GO:0060348 | 120 | 0.036 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.036 | |
| cellular response to alcohol | GO:0097306 | 23 | 0.036 | |
| pigment biosynthetic process | GO:0046148 | 26 | 0.035 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.035 | |
| histone deubiquitination | GO:0016578 | 2 | 0.035 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.035 | |
| fat cell differentiation | GO:0045444 | 160 | 0.035 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.035 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.035 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.035 | |
| response to oxygen levels | GO:0070482 | 62 | 0.035 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.035 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.035 | |
| sister chromatid cohesion | GO:0007062 | 12 | 0.034 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.034 | |
| dendritic cell proliferation | GO:0044565 | 2 | 0.034 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.034 | |
| lung cell differentiation | GO:0060479 | 30 | 0.034 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.034 | |
| neuron projection guidance | GO:0097485 | 141 | 0.034 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.034 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.034 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.034 | |
| cellular response to peptide | GO:1901653 | 92 | 0.033 | |
| neuronal stem cell maintenance | GO:0097150 | 17 | 0.033 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.033 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.033 | |
| cytoplasmic mrna processing body assembly | GO:0033962 | 6 | 0.033 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.033 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.033 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.033 | |
| response to acid chemical | GO:0001101 | 111 | 0.033 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.033 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.033 | |
| mesodermal cell differentiation | GO:0048333 | 22 | 0.033 | |
| endocrine system development | GO:0035270 | 98 | 0.032 | |
| response to monosaccharide | GO:0034284 | 67 | 0.032 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.032 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.032 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.032 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.032 | |
| regulation of posttranscriptional gene silencing | GO:0060147 | 5 | 0.032 | |
| response to insulin | GO:0032868 | 100 | 0.032 | |
| response to oxidative stress | GO:0006979 | 123 | 0.031 | |
| molting cycle | GO:0042303 | 90 | 0.031 | Worm |
| cellular response to nitric oxide | GO:0071732 | 4 | 0.031 | |
| regulation of activin receptor signaling pathway | GO:0032925 | 10 | 0.031 | |
| regulation of antibacterial peptide production | GO:0002786 | 1 | 0.031 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.031 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.031 | |
| regulation of cell motility | GO:2000145 | 236 | 0.031 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.030 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.030 | |
| neural tube patterning | GO:0021532 | 43 | 0.030 | |
| endoderm development | GO:0007492 | 45 | 0.030 | |
| immune effector process | GO:0002252 | 321 | 0.030 | |
| oxidation reduction process | GO:0055114 | 342 | 0.030 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.030 | |
| trachea development | GO:0060438 | 18 | 0.030 | |
| response to uv | GO:0009411 | 44 | 0.030 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.030 | |
| gastrulation with mouth forming second | GO:0001702 | 29 | 0.030 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.030 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.029 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.029 | |
| negative regulation of mammary gland epithelial cell proliferation | GO:0033600 | 3 | 0.029 | |
| positive regulation of antimicrobial humoral response | GO:0002760 | 2 | 0.029 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.029 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.029 | |
| collecting duct development | GO:0072044 | 11 | 0.029 | |
| head morphogenesis | GO:0060323 | 34 | 0.029 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.029 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.029 | |
| regulation of clathrin mediated endocytosis | GO:2000369 | 4 | 0.029 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.029 | |
| protein localization to membrane | GO:0072657 | 108 | 0.029 | |
| cellular response to radiation | GO:0071478 | 28 | 0.029 | |
| regulation of secretion | GO:0051046 | 274 | 0.029 | |
| tube closure | GO:0060606 | 91 | 0.028 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.028 | |
| cell adhesion | GO:0007155 | 329 | 0.028 | |
| neuromuscular process | GO:0050905 | 99 | 0.028 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.028 | |